Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection-Reference-Cited by-同舟云学术

Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection

Published:2017-02-25 Issue:4 Volume:65 Page:1094-1103
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Kowdley Kris V.¹,Sundaram Vinay²,Jeon Christie Y.³,Qureshi Kamran⁴,Latt Nyan L.⁵,Sahota Amandeep⁵,Lott Stephen⁶,Curry Michael P.⁷,Tsai Naoky⁸,Chaiyakunapruk Nathorn⁹¹⁰¹¹¹²,Lee Yoori¹³,Petersen Jorg¹⁴,Buggisch Peter¹⁴

Affiliation:

1. Liver Care Network; Swedish Medical Center; Seattle WA

2. Department of Medicine and Comprehensive Transplant Center; Cedars-Sinai Medical Center; Los Angeles CA

3. Samuel Oschin Cancer Center; Cedars-Sinai Medical Center; Los Angeles CA

4. Department of Medicine; Temple University Lewis Katz School of Medicine; Philadelphia PA

5. Department of Medicine; Kaiser Permanente Los Angeles Medical Center; Los Angeles CA

6. Burmans-Diplomat Specialty Pharmacy; Flint MI

7. Department of Medicine; Beth Israel Deaconess Medical Center; Boston MA

8. Department of Medicine; University of Hawaii; Honolulu HI

9. School of Pharmacy; Monash University Malaysia; Malaysia

10. Centre of Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences; Naresuan University; Phitsanulok Thailand

11. School of Population Health; University of Queensland; Brisbane Australia

12. School of Pharmacy; University of Wisconsin-Madison; Madison WI

13. TRIO Health Analytics; La Jolla CA

14. IFI Institut für Interdisziplinäre Medizin, Asklepios Klinik St. Georg; Hamburg Germany

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29005/fullpdf

Reference31 articles.

1. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis;Kowdley;N Engl J Med,2014